The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors

View/ Open
Issue date
2009Author
Landa, Iñigo
Ruiz-Llorente, Sergio
Montero-Conde, Cristina
Inglada-Pérez, Lucía
Schiavi, Francesca
Leskelä, Susanna
Pita, Guillermo
Milne, Roger
Maravall Royo, Javier
Ramos, Ignacio
Andía, Víctor
Rodríguez-Poyo, Paloma
Jara-Albarrán, Antonino
Meoro, Amparo
Peso, Cristina del
Arribas, Luis
Iglesias, Pedro
Caballero, Javier
Serrano, Joaquín
Picó, Antonio
Pomares, Francisco
Giménez, Gabriel
López-Mondéjar, Pedro
Castello, Roberto
Merante-Boschin, Isabella
Pelizzo, Maria-Rosa
Opocher, Giuseppe
Rodríguez-Antona, Cristina
González- Neira, Anna
Santisteban, Pilar
Robledo, Mercedes
Suggested citation
Landa, Iñigo;
Ruiz-Llorente, Sergio;
Montero-Conde, Cristina;
Inglada-Pérez, Lucía;
Schiavi, Francesca;
Leskelä, Susanna;
...
Robledo, Mercedes.
(2009)
.
The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.
PLoS Genetics, 2009, vol. 5, núm. 9, e1000637.
https://doi.org/10.1371/journal.pgen.1000637.
Metadata
Show full item recordAbstract
In order to identify genetic factors related to thyroid cancer susceptibility, we adopted a candidate gene approach. We studied
tag- and putative functional SNPs in genes involved in thyroid cell differentiation and proliferation, and in genes found to be
differentially expressed in thyroid carcinoma. A total of 768 SNPs in 97 genes were genotyped in a Spanish series of 615 cases
and 525 controls, the former comprising the largest collection of patients with this pathology froma single population studied
to date. SNPs in an LD block spanning the entire FOXE1 gene showed the strongest evidence of association with papillary
thyroid carcinoma susceptibility. This association was validated in a second stage of the study that included an independent
Italian series of 482 patients and 532 controls. The strongest association results were observed for rs1867277 (OR[perallele]
= 1.49; 95%CI = 1.30–1.70; P = 5.961029). Functional assays of rs1867277 (NM_004473.3:c.2283G.A) within the FOXE1
59 UTR suggested that this variant affects FOXE1 transcription. DNA-binding assays demonstrated that, exclusively, the
sequence containing the A allele recruited the USF1/USF2 transcription factors, while both alleles formed a complex in which
DREAM/CREB/aCREM participated. Transfection studies showed an allele-dependent transcriptional regulation of FOXE1. We
propose a FOXE1 regulation model dependent on the rs1867277 genotype, indicating that this SNP is a causal variant in
thyroid cancer susceptibility. Our results constitute the first functional explanation for an association identified by a GWAS and
thereby elucidate a mechanism of thyroid cancer susceptibility. They also attest to the efficacy of candidate gene approaches
in the GWAS era.
Is part of
PLoS Genetics, 2009, vol. 5, núm. 9, e1000637European research projects
Collections
The following license files are associated with this item: